Rebalix
Vanguard · sheet of 5 September 2026
Vanguard · sheet of 5 September 2026ETF sheet · official issuer and register data
Vanguard FTSE Japan UCITS ETF (USD) Distributing
VJPN · IE00B95PGT31 · USD · domicile Ireland
Equity · JapanSFDR art. 6 (inferred)
Index tracked: FTSE Japan Index
- TER
- 0.10%+ trans. 0.02%
- Fund size
- 4.3 bn EUR
- Tracking difference
- −0.10%3-year avg
- 🇮🇹 tax rate
- 26.00%equity
- Replication
- Physical (sampled)
- Income
- Distributingquarterly
Launch 21 May 2013 · costs from the KID as of 2 Sept 2026 · 513 securities held · 11 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Japan Index (the “Index”). The Index is comprised of large and mid-sized company stocks in Japan. The Fund attempts to: 1. Track the performance of the Index by investing through physical acquisition in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in…
Performance since series start (in euro) — base 100
30 Jun 2013 → 31 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +32.4% |
| 3 years | +55.3% |
| 5 years | +62.3% |
| 10 years | +144.4% |
| Since series start | +215.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 21.09% | 21.81% | 20.40% |
| Max drawdown | −13.77% | −19.56% | −34.65% |
| Sharpe | 1.15 | 0.68 | 0.32 |
| Sortino | 1.76 | 0.98 | 0.45 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VJPN · IE00B95PGT311
RebalixVJPN · IE00B95PGT31 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +25.18% | +25.30% | −0.11% |
| 2024 | +7.67% | +7.79% | −0.11% |
| 2023 | +19.49% | +19.57% | −0.08% |
| 2022 | −15.89% | −15.80% | −0.09% |
| 2020 | +14.05% | +14.19% | −0.14% |
Distributions · per share, in USD
Frequency: quarterly · last 12 months: 0.8813 USD (1.66% of NAV) · last ex-date 18 Jun 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.4422 | — |
| 2025 | 4 | 0.8357 | +2.32% |
| 2024 | 4 | 0.7027 | +2.06% |
| 2023 | 4 | 0.6393 | +2.20% |
| 2022 | 4 | 0.6341 | +1.80% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 513 securities · top-10 weight = 24.3%
| Top holdings | Weight |
|---|---|
| 3.8% | |
| 3.2% | |
| 2.4% | |
| 2.4% | |
| 2.3% | |
| 2.3% | |
| 2.2% | |
| 2.0% | |
| 1.9% | |
| 1.7% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VJPN · Borsa Italiana (ETFplus), Euronext Amsterdam, Euronext Paris, Xetra (Deutsche Börse)
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 13 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00B95PGT31
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00B95PGT31
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VJPN · IE00B95PGT312